Peer review reports
From: CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
| Original Submission |
| 27 May 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
| Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
| Publishing |
| 31 Aug 2016 |
Editorially accepted |
|
| 5 Sep 2016 |
Article published |
10.1186/s12885-016-2756-5
|
Learn about peer review
